Here’s how retatrutide works and how it differs from existing weight management medications.

G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight loss. Known as ...

A new class of weight loss drugs has already reshaped how people think about fat loss, but retatrutide is positioning itself ...

Please provide your email address to receive an email when new articles are posted on . Retatrutide, a GLP-1/GIP/glucagon receptor agonist, was linked to improved health-related quality of life and ...

Eli Lilly’s experimental weight-loss drug retatrutide led to an average weight reduction of up to 28.7%—more than 71 pounds—in adults with obesity or overweight and knee osteoarthritis. Participants ...

“It’s definitely the most effective means ever created through science to reduce the storage of fat,” one expert told GQ.

TRANSCEND-T2D-1 trial findings indicate that retatrutide provides significant improvements in HbA1c and cardiovascular risk factors. Topline results were announced from a phase 3 trial evaluating ...

iPercent change in the WOMAC pain subscale score and percent change in the WOMAC physical function subscale score were not pre-specified and were estimated from a post-hoc analysis.iiNot controlled ...

Please provide your email address to receive an email when new articles are posted on . Adults with obesity and knee osteoarthritis had reductions in body weight and knee pain with retatrutide. More ...

Retatrutide — an experimental drug nicknamed “triple G” — could be your best shot at a slimmer waistline when it becomes available to the public, a Monday study found. Obese adults who took the weekly ...